Broad host mucosa, intestinal epithelial cells, and gut microbiota

The broad host mucosa, intestinal epithelial cells, and gut microbiota constitute the complex biological interface of the gastrointestinal tract. This system functions as a critical barrier that regulates the absorption of nutrients while preventing the entry of harmful pathogens and toxins (PubMed: 28123350). Intestinal epithelial cells act as the primary physical partition, utilizing tight junction proteins to maintain selective permeability. The overlying mucus layer, produced by goblet cells, provides a biochemical shield and a niche for the gut microbiota. The microbiota itself is a diverse community of bacteria, fungi, and viruses that play essential roles in metabolic homeostasis and immune system education (NIH: PMC3426293). Disruptions to this tripartite relationship, often termed dysbiosis or "leaky gut," are linked to various pathologies including inflammatory bowel disease and metabolic syndrome (StatPearls: NBK470312). Therapeutic strategies targeting this environment include the use of probiotics to restore microbial balance and biologics to reduce mucosal inflammation. Because this is a multi-component system rather than a single molecular entity, it presents unique challenges for drug specificity and delivery.

Other names

Gastrointestinal barrierGut-microbiome-mucosa axisIntestinal nicheIntestinal mucosal barrier

Modulation of microbial composition, enhancement of epithelial barrier integrity, inhibition of pro-inflammatory cytokine production, and competitive exclusion of pathogens.